AbbVie/Roche drug gets U.S. approval for a rare type of leukemia

WASHINGTON (Reuters) - AbbVie Inc won U.S. regulatory approval on Monday for a new drug to treat patients with a rare type of chronic lymphocytic leukemia, a blood cancer.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro